Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic and Non-Diabetic Patients with Advanced Chronic Kidney Disease in Peritoneal Dialysis on Residual Kidney Function: In Real-World Data.
鈉-葡萄糖共轉運蛋白 2 抑制劑在接受腹膜透析的糖尿病及非糖尿病晚期慢性腎病患者中對殘餘腎功能的影響:來自真實世界數據的研究。
Medicina (Kaunas) 2024-08-30
The efficacy and safety of SGLT2 inhibitors in patients with non-diabetic chronic kidney disease: a systematic review and meta-analysis.
非糖尿病慢性腎臟病患者中SGLT2抑制劑的療效和安全性:系統性回顧和荟萃分析。
Int Urol Nephrol 2023-10-30
SGLT-2 inhibitors may increase ultrafiltration in incident peritoneal dialysis patients: a case report.
SGLT-2 抑制劑可能增加新發起腹膜透析患者的超濾。
BMC Nephrol 2023-05-04
Efficacy and Safety of the Use of SGLT2 Inhibitors in Patients on Incremental Hemodialysis: Maximizing Residual Renal Function, Is There a Role for SGLT2 Inhibitors?
在逐步透析患者中使用SGLT2抑制劑的功效和安全性:最大化殘餘腎功能,SGLT2抑制劑是否有作用?
Biomedicines 2023-07-31
Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Nondiabetic Patients with Chronic Kidney Disease: A Review of Recent Evidence.
非糖尿病患者慢性腎病患者使用鈉葡萄糖共轉運輸蛋白-2抑制劑的療效和安全性:近期證據回顧。
Kidney Dis (Basel) 2023-10-31
Narrative review investigating the nephroprotective mechanisms of sodium glucose cotransporter type 2 inhibitors in diabetic and nondiabetic patients with chronic kidney disease.
探討二型鈉葡萄糖共轉運輸蛋白抑制劑在糖尿病和非糖尿病慢性腎臟病患者中的腎保護機制的敘述性綜論。
Front Endocrinol (Lausanne) 2024-03-04
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria.
非糖尿病患者中鈉葡萄糖共同轉運蛋白2抑制劑對慢性腎臟病進展的實際效果:有無白蛋白尿的患者。
Diabetes Obes Metab 2024-04-29
Effects on calcium phosphate homeostasis after sodium-glucose cotransporter 2 inhibitor in patients with advanced chronic kidney disease and type 2 diabetes mellitus.
在晚期慢性腎病和第二型糖尿病患者中,鈉-葡萄糖共轉運蛋白 2 抑制劑對鈣磷穩態的影響。
Diabetes Res Clin Pract 2024-08-11
Retrospective analysis of the effect of SGLT-2 inhibitors on renal function in patients with type 2 diabetes in the real world.
SGLT-2 抑制劑對於真實世界中 2 型糖尿病患者腎功能影響的回顧性分析。
Front Pharmacol 2024-08-20
Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease.
鈉-葡萄糖共轉運蛋白 2 抑制劑對糖尿病及晚期慢性腎病患者心血管和腎臟結果的影響。
Diabetologia 2024-08-29